RJ

Robert A. Galemmo, Jr.

RP Rhone-Poulenc Rorer Pharmaceuticals: 7 patents #12 of 155Top 8%
RP Rorer Pharmaceutical: 7 patents #11 of 98Top 15%
Johnson & Johnson: 6 patents #1,608 of 7,810Top 25%
BS Bristol-Myers Squibb: 5 patents #1,010 of 3,969Top 30%
DP Dupont Pharmaceuticals: 4 patents #25 of 197Top 15%
MT Mirati Therapeutics: 3 patents #28 of 63Top 45%
SI Southern Research Institute: 3 patents #47 of 244Top 20%
CO Cortexyme: 3 patents #6 of 8Top 75%
EP Elan Pharmaceuticals: 2 patents #115 of 269Top 45%
TF The Uab Research Foundation: 1 patents #374 of 813Top 50%
DP Dupont Merck Pharmaceutical: 1 patents #121 of 228Top 55%
📍 San Francisco, CA: #548 of 26,999 inventorsTop 3%
🗺 California: #9,121 of 386,348 inventorsTop 3%
Overall (All Time): #62,684 of 4,157,543Top 2%
46
Patents All Time

Issued Patents All Time

Showing 26–46 of 46 patents

Patent #TitleCo-InventorsDate
6403620 Inhibitors of factor Xa with a neutral P1 specificity group Celia Dominguez, John M. Fevig, Qi Han, Patrick Lam, Donald J. P. Pinto +2 more 2002-06-11
6271237 Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors Lori Bostrom, Donald J. P. Pinto, Karen A. Rossi 2001-08-07
6060462 Electrophilic peptide analogs as inhibitors of trypsin-like enzymes Matthew Abelman, Eugene C. Amparo, John M. Fevig, Robert Knabb, William Henry Miller +3 more 2000-05-09
5998424 Inhibitors of factor Xa with a neutral P1 specificity group Celia Dominguez, John M. Fevig, Qi Han, Patrick Lam, Donald J. P. Pinto +2 more 1999-12-07
5939418 Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors Mimi L. Quan, John Wityak, Petrus Fredericus Wilhelmus Stouten, James R. Pruitt, Donald J. P. Pinto 1999-08-17
5925635 N-(amidinophenyl) cyclourea analogs as factor XA inhibitors Thomas P. Maduskuie, Jr., Celia Dominguez, Mimi L. Quan, Karen A. Rossi, Petrus Fredericus Wilhelmus Stouten +2 more 1999-07-20
5468898 Substituted naphthylene compounds exhibiting selective leukotriene B.sub.4 antagonist activity Fu-Chih Huang, Wan-Kit Chan, Charles A. Sutherland 1995-11-21
5232948 Substituted monocyclic aryl compounds exhibiting selective leukotriene B.sub.4 antagonist activity Fu-Chih Huang, Wan-Kit Chan, Charles A. Sutherland, Michael N. Chang 1993-08-03
5210208 Disubstituted aryl compounds exhibiting selective leukotriene B4 antagonist activity Fu-Chih Huang, Wan-Kit Chan, Charles A. Sutherland, Michael N. Chang 1993-05-11
5166210 Quinoline derivatives as antagonists of leukotriene D4 Fu-Chi Huang, Henry F. Campbell 1992-11-24
5059610 Quinoline derivatives and their use as antagonists of leukotriene D.sub.4 Fu-Chi Huang, Henry F. Campbell 1991-10-22
5051427 Quinoline derivatives as antagonists of leukotriene D.sub.4 Fu-Chi Huang, Henry F. Campbell 1991-09-24
5028615 Quinoline derivatives as antagonists of leukotriene D4 Fu-Chi Huang, Henry F. Campbell 1991-07-02
4977162 Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments Fu-Chih Huang, Henry F. Campbell, Keith S. Learn 1990-12-11
4920131 Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4 Fu-Chi Huang, Henry F. Campbell 1990-04-24
4920130 Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4 Fu-Chi Huang, Henry F. Campbell 1990-04-24
4920132 Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4 Fu-Chi Huang, Henry F. Campbell 1990-04-24
4920133 Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4 Fu-Chi Huang, Henry F. Campbell 1990-04-24
4918081 Quinoline derivatives and use thereof as antagonists of leukotriene d4 Fu-Chi Huang, Henry F. Campbell 1990-04-17
4816583 3- and 5-(bicyclic ether or bicyclic alkylene thioether) alkylene amino thiatriazines Donald E. Kuhla, Henry F. Campbell, William L. Studt, Stuart A. Dodson, Pamela J. Durham 1989-03-28
4727169 3- and 5-(bicyclic ether or bicyclic alkylene thioether) alkylene amino thiatriazines, and their pharmaceutical uses Donald E. Kuhla, Henry F. Campbell, William L. Studt, Stuart A. Dodson, Pamela J. Durham 1988-02-23